Threats

Luckily, Medicis Aesthetics' capital position as a subsidiary of Medicis Pharmaceutical Corporation also enables it to better weather external threats to the company, which certainly exists for the industry as a whole. Threats of litigation are a very real factor of how this industry does business, especially with certain product lines. In addition, the industry is now facing the threat of a prolonged recession, which many analysts claim we are only in the beginnings of. If this proves to be the case, Medicis Aesthetics and its competitors will be faced with an ever-shrinking consumer pool. This will make competition fiercer and make profitability highly dependent on materials and labor costs.

Product Comparison

Two of Medici Aesthetics' most popular and currently profitable products are Restylane and Perlane, both of which are dermal fillers (non-surgical wrinkle removers) composed of hyaluronic acid. Though patented and using a relatively unique mechanism to achieve...
[ View Full Essay]